Please use this identifier to cite or link to this item:
http://ahro.austin.org.au/austinjspui/handle/1/13768| Title: | Temozolomide-associated liver fibrosis |
| Authors: | Parakh, Sagun;Hamid, Anis A;Cher, Lawrence M;Gan, Hui K |
| Affiliation: | Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia Olivia Newton-John Cancer Research Institute, Austin Health, Heidelberg, Victoria, Australia School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia |
| Issue Date: | Nov-2016 |
| EDate: | 2016-04-20 |
| Citation: | The Journal of Clinical Pharmacology 2016; 56(11): 1448-1449 |
| Abstract: | Temozolomide is generally well tolerated and severe hepatic toxicities associated with temozolomide are rare. We report a case of liver fibrosis in a patient on temozolomide for the treatment of GBM. This article is protected by copyright. All rights reserved. |
| URI: | http://ahro.austin.org.au/austinjspui/handle/1/13768 |
| DOI: | 10.1002/jcph.753 |
| ORCID: | 0000-0002-7193-9723 |
| PubMed URL: | http://www.ncbi.nlm.nih.gov/pubmed/27094014 |
| Type: | Journal Article |
| Subjects: | Temozolomide Liver Cirrhosis |
| Appears in Collections: | Journal articles |
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.